This systematic review and meta-analysis aimed to determine the efficacy of inhaled
corticosteroids (ICS) on mortality in patients with coronavirus disease-2019 (COVID-19). A …

Methods: A comprehensive literature search was conducted across the WHO, LitCOVID, and
EMBASE databases from inception until June 30th, 2022. The primary outcome was overall …

Background The effect of inhaled corticosteroids (ICS) on the clinical outcomes of patients
with coronavirus disease 2019 (COVID-19) was not known. Research design and methods …

Background The efficacy of inhaled corticosteroid (ICS) in the treatment of patients with
COVID-19 has been evaluated in randomized controlled trials (RCTs), however, their …

Background Covid-19 disease is caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2). Although corticosteroids have shown some promising results in Covid-19 …

Background To assess the efficacy and safety of corticosteroids in COVID-19 patients
compared with standard care or placebo. Methods Electronic databases were searched to …

Background More than six million people died due to COVID-19, and 10-15% of infected
individuals suffer from post-covid syndrome. Corticosteroids are widely used in the …

Introduction We conducted a comprehensive literature review to synthesize evidence for the
relationship between corticosteroid use and mortality in patients with COVID-19. Methods …

Background WHO quoted the numbers for the Coronavirus disease 2019 (COVID-19)
pandemic as of August 2021 were 200 million cases with over 4 million deaths globally …

The benefits and harms of corticosteroids for patients with severe coronavirus disease 2019
(COVID-19) remain unclear. We systematically searched PubMed, Embase, and Cochrane …